Long-Term Outcomes After Liver Transplantation (tx) with Everolimus (EVR) and Mycophenolic Acid (MPA) in a Calcineurin Inhibitor-Free Regimen: The CERTITUDE Trial

被引：0
|
作者：
Saliba, F. [1 ]
Duvoux, C. [2 ]
Dharancy, S. [3 ]
Dumortier, J. [4 ]
Calmus, Y. [5 ]
Di Giambattista, F. [6 ]
Conti, F. [5 ]
机构：
[1] Hop Paul Brousse, AP HP, Villejuif, France
[2] Hop Henri Mondor, AP HP, Creteil, France
[3] CHRU Lille, Lille, France
[4] Hop Edouard Herriot, Lyon, France
[5] Hop La Pitie Salpetriere, AP HP, Paris, France
[6] Novartis Pharma SAS, Rueil Malmaison, France
来源：
AMERICAN JOURNAL OF TRANSPLANTATION | 2017年 / 17卷
关键词：
D O I：
暂无
中图分类号：
R61 [外科手术学];
学科分类号：
摘要：
524
引用
收藏
页码：392 / 392
页数：1
相关论文
共 33 条
  • [1] Long-Term Results in Recipients of Late Conversion to a Calcineurin Inhibitor-Free Regimen with Everolimus After Kidney Transplantation
    Iwahara, Naoya
    Hotta, Kiyohiko
    Hirose, Takayuki
    Shinohara, Nobuo
    [J]. TRANSPLANTATION PROCEEDINGS, 2023, 55 (04) : 803 - 808
  • [2] Long-term Effect on Albuminuria and Glomerular Filtration Rate of a Calcineurin Inhibitor-Free Everolimus Based Immunosuppressive Regimen after Heart Transplantation
    Nelson, L. M.
    Andreassen, A. K.
    Andersson, B.
    Gude, E.
    Eiskjaer, H.
    Raadegran, G.
    Dellgren, G.
    Gullestad, L.
    Gustafsson, F.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2016, 35 (04): : S280 - S280
  • [3] Long-Term Renoprotective Effect of Sirolimus-Based Calcineurin Inhibitor-Free Immunosuppression after Cardiac Transplantation
    Choi, J-O
    Riaz, T.
    Boilson, B. A.
    Schirger, J. A.
    Pereira, N. L.
    Clavell, A. L.
    Frantz, R. P.
    Daly, R. C.
    Edwards, B. S.
    Park, S. J.
    Rodeheffer, R. J.
    Kushwaha, S. S.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2013, 32 (04): : S115 - S115
  • [4] Comparison of Long Term Survival Outcomes for Everolimus (EVR) vs. Mycophenolic Acid (MPA) Immunosuppressive Regimens Post Kidney Transplant
    Cibrik, D.
    Irish, W.
    McCague, K.
    Patel, D.
    Tedesco, H.
    [J]. AMERICAN JOURNAL OF TRANSPLANTATION, 2017, 17 : 735 - 735
  • [5] Are Calcineurin Inhibitor-Free Protocols Safe and Effective in the Long-Term After Heart Transplant?
    Patel, J.
    Kittleson, M.
    Kransdorf, E.
    Patel, N.
    Singer-Englar, T.
    Hu, J.
    Kim, S.
    Trento, A.
    Czer, L.
    Kobashigawa, A.
    [J]. JOURNAL OF HEART AND LUNG TRANSPLANTATION, 2022, 41 (04): : S339 - S339
  • [6] Effect of Calcineurin Inhibitor-Free, Everolimus-Based Immunosuppressive Regimen on Albuminuria and Glomerular Filtration Rate After Heart Transplantation
    Nelson, Laerke Marie
    Andreassen, Arne Kristian
    Andersson, Bert
    Gude, Einar
    Eiskjaer, Hans
    Radegran, Goran
    Dellgren, Goran
    Gullestad, Lars
    Gustafsson, Finn
    [J]. TRANSPLANTATION, 2017, 101 (11) : 2793 - 2800
  • [7] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE
    Saliba, Faouzi
    Duvoux, Christophe
    Dharancy, Sebastien
    Dumortier, Jerome
    Calmus, Yvon
    Gugenheim, Jean
    Kamar, Nassim
    Salame, Ephrem
    Cransac, Martine Neau
    Vanlemmens, Claire
    Durand, Francois
    Pageaux, Georges Philippe
    Hardwigsen, Jean
    Tindel, Malka
    Masson, Cecile
    Gharbi, Hakam
    Conti, Filomena
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 220 - 220
  • [8] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): THREE-YEAR FINDINGS FROM CERTITUDE
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Gugenheim, J.
    Kamar, N.
    Salame, E.
    Neau-Cransac, M.
    Vanlemmens, C.
    Durand, F.
    Pageaux, G.
    Hardwigsen, J.
    Tindel, M.
    Masson, C.
    Gharbi, H.
    Conti, F.
    [J]. TRANSPLANT INTERNATIONAL, 2019, 32 : 18 - 18
  • [9] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): FOUR-YEAR FINDINGS FROM CERTITUDE
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Gugenheim, J.
    Kamar, N.
    Salame, E.
    Neau-Cransac, M.
    Vanlemmens, C.
    Durand, F.
    Pageaux, G.
    Hardwigsen, J.
    Kamar, D.
    Capela, D.
    Gharbi, H.
    Conti, F.
    [J]. TRANSPLANT INTERNATIONAL, 2020, 33 : 26 - 26
  • [10] RENAL, EFFICACY AND SAFETY OUTCOMES USING AN EVEROLIMUS (EVR)-BASED CALCINEURIN INHIBITOR (CNI)-FREE REGIMEN VERSUS STANDARD TACROLIMUS (TAC) AFTER LIVER TRANSPLANT (LTX): TWO-YEAR FINDINGS FROM CERTITUDE
    Saliba, F.
    Duvoux, C.
    Dharancy, S.
    Dumortier, J.
    Calmus, Y.
    Gugenheim, J.
    Kamar, N.
    Salame, E.
    Neau-Cransac, M.
    Vanlemmens, C.
    Durand, F.
    Pageaux, G.
    Hardwigsen, J.
    Dawson, M. Ktiouet
    Conti, F.
    [J]. TRANSPLANT INTERNATIONAL, 2018, 31 : 15 - 16
1234